Your browser doesn't support javascript.
loading
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis.
Wen, Wen; Chen, Chen; Tang, Jiake; Wang, Chunyi; Zhou, Mengyun; Cheng, Yongran; Zhou, Xiang; Wu, Qi; Zhang, Xingwei; Feng, Zhanhui; Wang, Mingwei; Mao, Qin.
Afiliação
  • Wen W; Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou, PR China.
  • Chen C; Hangzhou Normal University, Hangzhou, PR China.
  • Tang J; Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou, PR China.
  • Wang C; Hangzhou Normal University, Hangzhou, PR China.
  • Zhou M; Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou, PR China.
  • Cheng Y; Hangzhou Normal University, Hangzhou, PR China.
  • Zhou X; Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou, PR China.
  • Wu Q; Hangzhou Normal University, Hangzhou, PR China.
  • Zhang X; Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto, Japan.
  • Feng Z; School of Public Health, Hangzhou Medical College, Hangzhou, PR China.
  • Wang M; Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou, PR China.
  • Mao Q; Hangzhou Institute of Cardiovascular Diseases, Affiliated Hospital of Hangzhou Normal University, Hangzhou, PR China.
Ann Med ; 54(1): 516-523, 2022 12.
Article em En | MEDLINE | ID: mdl-35118917
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluvoxamina / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluvoxamina / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article